dr mary claire haver and glp 1 GLP-1 medications were never designed to be a quick fix., In this episode of unPAUSED, Dr. Michelle Gordon explains why GLP-1s are intended to treat obesity as the chronic disease it is, not to help MaryClaire Haver, MD, CCMS

Mounjaro is designed for those with type 2 diabetes, while Zepbound targets weight management

Case Example: ePA Workflow for a GLP-1 Prescription To illustrate, consider a hypothetical case: Patient: 55-year-old female with Type 2 diabetes (HbA1c 8.7%), BMI 34, on metformin + lifestyle modifications

Caffrey, M

However, a number of case reports and analysis of adverse effect databases raised the possibility that the drugs increase the incidence of acute pancreatitis

Ways in which you can combat this and get better results with GLP-1s include increasing your protein intake to around 1.21.6 g per kilogram of body weight per day and doing resistance training